Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $79.43 billion
- Book Value:
- Revenue TTM:
- $8.09 billion
- Operating Margin TTM:
- Gross Profit TTM:
- $5.63 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Zoetis Inc had its IPO on 2013-02-01 under the ticker symbol ZTS.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Zoetis Inc has a staff strength of 13,800 employees.
Shares of Zoetis Inc opened at $166.96 at the start of the last trading session i.e. 2023-06-03.
The stocks traded within a range of $166.51 - $172.47, and closed at $171.88.
This is a +3.54% increase from the previous day's closing price.
A total volume of 3,056,300 shares were traded at the close of the day’s session.
In the last one week, shares of Zoetis Inc have increased by +1.62%.
Zoetis Inc's Key Ratios
Zoetis Inc has a market cap of $79.43 billion, indicating a price to book ratio of 15.1706 and a price to sales ratio of 8.6561.
In the last 12-months Zoetis Inc’s revenue was $8.09 billion with a gross profit of $5.63 billion and an EBITDA of $3.28 billion. The EBITDA ratio measures Zoetis Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Zoetis Inc’s operating margin was 35.52% while its return on assets stood at 13.01% with a return of equity of 45.21%.
In Q1, Zoetis Inc’s quarterly earnings growth was a negative -5.6% while revenue growth was a positive 0.7%.
Zoetis Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $4.42 per share while it has a forward price to earnings multiple of 30.1205 and a PEG multiple of 3.5264. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Zoetis Inc’s profitability.
Zoetis Inc stock is trading at a EV to sales ratio of 9.3651 and a EV to EBITDA ratio of 23.1012. Its price to sales ratio in the trailing 12-months stood at 8.6561.
Zoetis Inc stock pays annual dividends of $1.35 per share, indicating a yield of 0.9% and a payout ratio of 28.75%.
Balance sheet and cash flow metrics
- Total Assets
- $13.75 billion
- Total Liabilities
- $1.92 billion
- Operating Cash Flow
- Capital Expenditure
- $223 million
- Dividend Payout Ratio
Zoetis Inc ended 2023 with $13.75 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $13.75 billion while shareholder equity stood at $4.49 billion.
Zoetis Inc ended 2023 with $131.00 million in deferred long-term liabilities, $1.92 billion in other current liabilities, 5000000.00 in common stock, $9.05 billion in retained earnings and $2.74 billion in goodwill. Its cash balance stood at $2.11 billion and cash and short-term investments were $2.11 billion. The company’s total short-term debt was $3,000,000 while long-term debt stood at $6.56 billion.
Zoetis Inc’s total current assets stands at $6.27 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $1.19 billion compared to accounts payable of $424.00 million and inventory worth $2.56 billion.
In 2023, Zoetis Inc's operating cash flow was $-216000000.00 while its capital expenditure stood at $223 million.
Comparatively, Zoetis Inc paid $0.29 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Zoetis Inc stock is currently trading at $171.88 per share. It touched a 52-week high of $187.82 and a 52-week low of $187.82. Analysts tracking the stock have a 12-month average target price of $215.08.
Its 50-day moving average was $173.23 and 200-day moving average was $159.81 The short ratio stood at 2.1 indicating a short percent outstanding of 0%.
Around 20% of the company’s stock are held by insiders while 9439.3% are held by institutions.
Frequently Asked Questions About Zoetis Inc
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.